Acorn Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$818K Buy
6,368
+281
+5% +$32.9K 0.2% 111
2026
Q1
$732K Buy
6,087
+16
+0.3% +$1.85K 0.21% 103
2025
Q4
$639K Sell
6,071
-222
-4% -$20.8K 0.19% 114
2025
Q3
$528K Buy
6,293
+88
+1% +$7.25K 0.17% 134
2025
Q2
$491K Sell
6,205
-963
-13% -$76.5K 0.18% 122
2025
Q1
$643K Buy
7,168
+64
+0.9% +$5.97K 0.27% 85
2024
Q4
$707K Sell
7,104
-7
-0.1% -$722 0.29% 77
2024
Q3
$808K Buy
7,111
+1,537
+28% +$183K 0.35% 63
2024
Q2
$690K Buy
5,574
+27
+0.5% +$3.48K 0.34% 68
2024
Q1
$732K Buy
5,547
+516
+10% +$63.6K 0.38% 61
2023
Q4
$548K Buy
5,031
+2
+0% +$208 0.33% 71
2023
Q3
$518K Buy
5,029
+86
+2% +$9.27K 0.34% 66
2023
Q2
$570K Sell
4,943
-84
-2% -$9.54K 0.39% 64
2023
Q1
$535K Sell
5,027
-403
-7% -$43.5K 0.39% 61
2022
Q4
$603K Sell
5,430
-28
-0.5% -$2.86K 0.46% 48
2022
Q3
$470K Buy
5,458
+77
+1% +$6.87K 0.39% 61
2022
Q2
$491K Buy
5,381
+22
+0.4% +$1.95K 0.39% 64
2022
Q1
$440K Buy
5,359
+24
+0.4% +$1.89K 0.3% 84
2021
Q4
$409K Buy
5,335
+22
+0.4% +$1.75K 0.26% 93
2021
Q3
$399K Buy
5,313
+18
+0.3% +$1.37K 0.28% 90
2021
Q2
$412K Sell
5,295
-230
-4% -$17.1K 0.28% 83
2021
Q1
$406K Buy
5,525
+21
+0.4% +$1.55K 0.29% 82
2020
Q4
$430K Buy
5,504
+222
+4% +$17K 0.34% 67
2020
Q3
$418K Sell
5,282
-102
-2% -$7.99K 0.37% 55
2020
Q2
$397K Buy
5,384
+21
+0.4% +$1.58K 0.37% 54
2020
Q1
$403K Buy
5,363
+141
+3% +$11.1K 0.45% 48
2019
Q4
$447K Hold
5,222
0.38% 55
2019
Q3
$423K Buy
5,222
+156
+3% +$12.5K 0.36% 57
2019
Q2
$417K Buy
5,066
+16
+0.3% +$1.23K 0.38% 55
2019
Q1
$379K Sell
5,050
-29
-0.6% -$2.17K 0.34% 61
2018
Q4
$368K Hold
5,079
0.38% 54
2018
Q3
$353K Buy
5,079
+107
+2% +$6.82K 0.35% 61
2018
Q2
$287K Hold
4,972
0.24% 85
2018
Q1
$284K Sell
4,972
-105
-2% -$5.67K 0.25% 82
2017
Q4
$276K Buy
+5,077
New +$281K 0.25% 80

Other funds holding MRK

Acorn Wealth Advisors's MRK Position: Q2 2026 in Review

Acorn Wealth Advisors increased its Merck (MRK) stake by 4.6% in Q2 2026, buying an estimated $32.9K and bringing the position to 6,368 shares worth $818K. The position accounts for 0.2% of the portfolio, ranked #111.

Acorn Wealth Advisors first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Acorn Wealth Advisors held 6,368 shares of Merck worth $818K as of Q2 2026.
  • Acorn Wealth Advisors bought 281 Merck shares in Q2 2026, an estimated $32.9K.
  • Merck made up 0.2% of Acorn Wealth Advisors's portfolio in Q2 2026, its #111 holding.
  • Acorn Wealth Advisors first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Acorn Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.